We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Breviscapine suppresses the growth of non-small cell lung cancer by enhancing microRNA-7 expression.
- Authors
Zeng, Jian; Cai, Shunv
- Abstract
Breviscapine (BVP) has previously been shown to inhibit the proliferation of hepatocellular carcinoma cells. However, little is known about the effects of BVP on non-small cell lung cancer (NSCLC) growth. Here, we aimed to study the effects of BVP on human NSCLC growth. We employed A549, NCL-H460 and A549 cells transfected with microRNA-7 (miR-7) mimic and inhibitor to investigate the effect of BVP on cell proliferation, apoptosis and apoptosis-associated molecules. The results showed that BVP significantly reduced the growth of A549 and NCL-H460 cells in a concentration-dependent and time-dependent manner, accompanied by a significant elevation of apoptosis. Additionally, the present study also confirmed that BVP-treated A549 cells showed increased levels of Bax and microRNA-7 (miR-7) and a decreased level of Bcl-2. The up-regulation of miR-7 enhanced the BVP sensitivity of NSCLC cells by suppressing cell proliferation and promoting cell apoptosis, while the inhibition of miR-7 reversed the anti-proliferative pro-apoptotic effects of BVP. Pre-treatment with miR-7 mimics enhanced the BVP-mediated down-regulation of Bax/Bcl-2 in NSCLC cells, while pre-treatment with the miR-7 inhibitor blocked the BVP-mediated down-regulation of Bax/Bcl. Taken together, these results confirm that BVP effectively inhibits NSCLC proliferation and that miR-7, as a novel target, is likely involved in BVP-induced growth suppression and the apoptosis of NSCLC cells.
- Subjects
FLAVONOIDS; NON-small-cell lung carcinoma; TUMOR growth prevention; MICRORNA genetics; GENE expression; ANTINEOPLASTIC agents; GENETICS; THERAPEUTICS
- Publication
Journal of Biosciences, 2017, Vol 42, Issue 1, p121
- ISSN
0250-5991
- Publication type
Article
- DOI
10.1007/s12038-017-9670-0